Month: January 2022

January 26, 2022

Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the industry’s first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution is the most advanced patient-centric ECG offering within the company’s cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services. This latest addition to Philips’ digitally enabled suite of monitoring solutions helps to drive innovation across the care continuum and support the decentralized clinical trial space.

Patient attrition is one of the biggest issues faced by clinical trial sponsors seeking regulatory approval for new therapies. Attrition over the course of a study can reduce the quality of its findings and can lead to longer, more expensive trials that require higher than optimal recruiting rates to compensate. Voluntary patient withdrawal is often tied to disease progression or the prolonged inconvenience of adhering to protocol regimens and repetitive site visits [1]. By offering the consistent and reliable standards of a 12-lead ECG in the comfort and convenience of a patient’s home, Philips at-home ECG solution aims to improve trial recruitment, compliance and patient retention by reducing the need for and burden of site visits.

“Our customers are seeking solutions that will help them to address key challenges that can stand in the way of extracting meaningful insights from their clinical trials,” said Andy Broadway, General Manager of Ambulatory Monitoring and Diagnostics at Philips. “Our growing portfolio of remote monitoring solutions help to curb patient attrition by reducing the amount of site visits required during the trial period, helping to improve both the quality of the outcome and the patient experience overall.”

Leveraging PCA 500 ECG patch data recording technology, the at-home solution allows clinical trial participants to record data with quality comparable to site-based ECGs at home. The solution’s innovative body-worn patch ensures compliant 12-lead ECG placement and near real-time, highly secure data transmission without the need for recurring site visits, onsite technician, or home nurses.

Philips offers a complete range of clinically validated ambulatory cardiac diagnostics and monitoring services and associated expertise to its cardiac care portfolio, including its BioTel Research capabilities that have already supported more than 2,000 clinical trials in 72 countries. These comprehensive offerings provide industry-leading technology and data management that streamlines the clinical trials process and ensures optimal performance. The at-home, 12-lead ECG solution is now available in select markets across North America, Europe and Asia.

[1] Hui D, Glitza I, Chisholm G, Yennu S, Bruera E. Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer. 2013;119(5):1098-1105. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568443/

For further information, please contact:

Meredith Amoroso
Philips Global Press Office
Tel: +1 724-584-8991
E-mail: meredith.amoroso@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

• Philips introduces first at-home, 12 lead ECG integrated solution for decentralized clinical trials
• Philips new at-home, 12 lead ECG solution helps to reduce need for site visits during clinical trials

Featured Image for 4me, Inc.

Featured Image for 4me, Inc.

PALO ALTO, Calif., Jan. 26, 2022 (GLOBE NEWSWIRE) — Another new integration has been added to the flourishing 4me® App Store, ready to use by all 4me customers. The 4me Lansweeper app is a one-directional, out-of-the-box integration between Lansweeper Enterprise Cloud and 4me that synchronizes IT asset data with the 4me configuration management database (CMDB).

Cor Winkler Prins, CEO at 4me: “It is great news that we can now offer our customers this integration between Lansweeper and 4me in the form of an easy-to-use app. With our complete service management platform, we strive to provide seamless cross-enterprise visibility and collaboration and connecting and centralizing IT Asset Data is essential to help companies achieve this.”

Cassandra Lloyd, Partner Alliance Manager at Lansweeper: “At Lansweeper, we believe in connecting knowledge, technology, and new ideas to improve the way we all work together. Our customers do too, and we find that more and more of them use 4me to manage their service management. Being able to offer them this integration as an App will make the integration between 4me and Lansweeper even easier to implement.”

4me as a Single Source of Truth
Keeping asset data up to date can be challenging for larger organizations. Lansweeper is an IT Asset Management (ITAM) solution that automatically gathers hardware and software information of computers and other devices on a computer network.

4me’s service management platform is built to enable seamless collaboration between multiple service providers with complete cross-enterprise visibility and control. Many 4me customers use Lansweeper to stay in control of their asset data. Maintaining these assets in the service management solution allows them to be related to assignments. This makes it easier for support specialists to find hardware items or find out what other issues have affected a CI in the past.

The 4me Lansweeper App
Organizations that use both 4me and Lansweeper can now easily integrate both platforms by activating the 4me Lansweeper app in the 4me App Store. The first time the app is used, all physical assets from the Lansweeper inventory are swiftly imported into 4me. From then on, administrators can decide exactly which data to import on a daily basis to maintain the asset data up to date in the service management application.

Emile Fourie, Specialist: Service Process Optimisation at Dimension Data: “We have already tested the integration and were greatly impressed with the results. Connecting and centralizing our IT asset data in 4me in this way will be of great value to us and increase visibility and efficiency.”

The installation process is straightforward and explained step by step in a 4me knowledge article.

The 4me App Store
As the number of standard integrations with 4me continues to grow, the 4me App Store is also rapidly growing. It offers more and more standard 4me integrations and presents them in a way that makes them easy to manage by administrators.

About 4me – The Complete Service Management Platform
4me® combines ITSM with ESM and SIAM capabilities, enabling all internal departments, such as IT, HR, and Facilities, as well as external managed service providers, to work seamlessly with each other. At the same time, 4me provides complete visibility and control of service cost and quality.

About Lansweeper
Lansweeper is an IT asset management software provider helping businesses better understand, manage and protect their IT devices and network. Lansweeper helps customers minimize risks and optimize their IT assets by providing actionable insight into their IT infrastructure at all times, offering trustworthy, valuable, and accurate insights about the state of users, devices, and software.

Press contact: gertje.bosma@4me.com

Related Image

Image 1

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Featured Image for 4me, Inc.

เตเมคูลา แคลิฟอร์เนีย, Jan. 26, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (Group) ซึ่งเป็นบริษัทในเครือ Nikkiso Co., Ltd (Japan) ยินดีที่จะประกาศว่า Kevin Shelly ได้รับแต่งตั้งให้เป็นนักยุทธศาสตร์การขายของ the Nikkiso Cryogenic Pumps Unit – Americas

ตำแหน่งใหม่ที่มีสำคัญสำหรับทีมผู้บริหารนี้สนับสนุนวัตถุประสงค์ของกลุ่มเพื่อขยายการมีอยู่และอิทธิพลภายในตลาดก๊าซอุตสาหกรรมทั่วอเมริกาเหนือและใต้

Kevin มีประวัติที่น่าประทับใจในด้านการพัฒนาการขาย การพัฒนาความสัมพันธ์กับลูกค้า การบริหารความสัมพันธ์ลูกค้ารายสำคัญและการบริหารจัดการพื้นที่การขายด้วยประสบการณ์ในอุตสาหกรรมมากกว่า 20 ปีของเขา เขาจะเน้นไปที่การขายอุปกรณ์ชั้นเยี่ยมตลอดจนบริการทั้งก่อนและหลังการขายในกลุ่มเครื่องปั๊ม นอกจากนี้ Kevin จะมีบทบาทสำคัญในกลยุทธ์ของกลุ่มด้วยการส่งเสริมโอกาสต่าง ๆ ให้กับกลุ่มบริษัท Nikkiso และปูทางสู่การเป็นหุ้นส่วนเชิงยุทธศาสตร์ที่แข็งแกร่งขึ้นเพื่อลูกค้าของเรา

Daryl Lamy ประธานและซีอีโอของหน่วยปั๊มของกลุ่มบริษัทกล่าวว่า “Pumps Unit รู้สึกตื่นเต้นที่ได้ Kevin เข้ามารับตำแหน่งใหม่ในการบริหารเชิงกลยุทธ์นี้” “ประสบการณ์หลายปีของเขาจะเพิ่มความสามารถของเราในการนำเสนอผลิตภัณฑ์ปั๊มไครโอเจนิค (cryogenic pump) ระดับโลก การบริการลูกค้า และโซลูชั่นการสร้างมูลค่าเพิ่มให้กับสินค้าหรือบริการเพื่อลูกค้าของเรา”

Nikkiso Cryogenic Pumps Unit ซึ่งรวมถึง Nikkiso ACD และ Nikkiso Cryo เป็นผู้ผลิตชั้นนำในกลุ่มผลิตภัณฑ์ปั๊มไครโอเจนิคที่หลากหลาย ตั้งแต่ขนาดเล็กไปจนถึงขนาดใหญ่

ข้อมูลเกี่ยวกับ CRYOGENIC INDUSTRIES
บริษัทสมาชิก Cryogenic Industries, Inc. (ปัจจุบันเป็นสมาชิกของ Nikkiso Co., Ltd.) ผลิตอุปกรณ์แปรรูปก๊าซไครโอเจนทางวิศวกรรมและโรงงานขนาดเล็กสำหรับแปรรูปก๊าซธรรมชาติเหลว (LNG) บริการจัดการหลุมปิโตรเลียมหลังการขุดเจาะ และอุตสาหกรรมก๊าซสำหรับอุตสาหกรรม Cryogenic Industries ก่อตั้งขึ้นเมื่อ 50 ปีที่แล้ว โดยเป็นบริษัทแม่ของ ACD, Cosmodyne และ Cryoquip และเป็นกลุ่มที่ควบคุมโดยทั่วไปซึ่งมีหน่วยงานปฏิบัติการประมาณ 20 แห่ง

สำหรับข้อมูลเพิ่มเติม โปรดไปที่ www.nikkisoCEIG.com และ www.nikkiso.com.

การติดต่อสำหรับสื่อ:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

• Amlan’s growing global investment in R&D and technical expertise in key global regions delivers next-generation mineral-based feed additive technologies.
• Already offering proven feed additives for global poultry and livestock production, Amlan introduces new natural, mineral-based feed additives for the US market to meet growing consumer demands for higher-quality animal protein raised without antibiotics.
• Emerging technologies for poultry and swine production optimize gut health in animals, support intestinal strength and encourage an animal’s innate response to disease pressures in a natural way.

ATLANTA, Jan. 25, 2022 (GLOBE NEWSWIRE) — Advancements in natural feed additives are transforming animal protein production by providing proven and reliable products to improve the sustainability of poultry and livestock production and meet growing consumer demand for cleaner food. This week at the International Production and Processing Expo (IPPE), an annual international event showcasing the latest technology used in the production and processing of poultry, Amlan International introduced next-generation natural mineral-based feed additives for producers and vertical integrators in the United States while showcasing its growing investment in R&D and technical support in key global markets.

“As the use of antibiotics in livestock production comes under increased scrutiny, the poultry industry has to act. More producers are under pressure to reduce the use of antibiotics in animal feed, which makes gut health in animals more important than ever,” says Dan Jaffee, President & General Manager of Amlan, President & CEO of Oil-Dri Corporation of America, a global leader in sorbent technologies.

“At IPPE this week, we’re showcasing our investment in next-generation technology of natural mineral-based feed additives that are supportive of normal animal gut health and immunity, without the use of antibiotics or harsh chemical additives. These attributes meet consumer’s demand for cleaner food while reducing the inputs needed to raise production animals. These factors work together synergistically to decrease the cost and environmental impact of poultry and livestock production,” says Dr. Wade Robey, Amlan Vice President, Marketing and Product Development.

Amlan already has a strong track record with its natural feed additives such as Varium^® for poultry and NeoPrime^® for swine in key international markets, including Latin America, Southeast Asia and China. New Amlan products launched in the United States and showcased this week at IPPE are helping to address the sustainability of animal production with natural feed additives that support intestinal health, animal welfare and economic performance in poultry and swine. They include Sorbiam^™, a single ingredient feed additive for optimizing gut health; Ambio^™-P and Ambio^™-S, naturally formulated to support intestinal strength in poultry and swine, respectively; AmSure,^™ for supporting optimal intestinal health, animal welfare and economic performance; and Enterotec,^™a formulation based on natural phytochemicals that supports normal intestinal integrity and function as chemical and ionophore compounds are removed from animal diets.

The natural feed additives are formulated to have strong synergy with each other without the use of in-feed antibiotic growth promoters (AGPs). The synergistic blends of the mineral with other feed additives further support normal gut function and digestive processes.

Designed and Made with the World in Mind
As the animal health business of Oil-Dri^® Corporation of America, a leader in sorbent mineral technology, Amlan leverages Oil-Dri’s mineral science expertise to develop proprietary, mineral-based feed additives. Amlan products are based on its natural mineral ingredient that undergoes thermal processing, without the use of harmful chemicals, specifically tailored for each of its products.

“Because Amlan and Oil-Dri are vertically integrated, the company controls the quality, reliability and safety of the mineral — from mine to feed,” says Fred Kao, Vice President of Global Sales for Amlan. “This is accomplished by following sustainable mining practices and using natural ingredients in our feed additive products.”

Investing in the Future
Looking to 2022, Amlan is poised for tremendous growth opportunities with its mineral-based animal health solutions. At Amlan’s Innovation Center in Vernon Hills, Illinois, USA, which houses the Richard M. Jaffee Laboratory for Applied Microbiology, the company’s Life Sciences team is focused on delivering the next evolution in natural, non-pharmaceutical feed additives for supporting normal intestinal function in poultry and livestock. The research facility was expanded in 2019 to support the recent growth of the company’s Life Sciences initiatives.

Amlan has also invested in expanding capabilities in key markets to support livestock producers and integrators. One example is in China, where Amlan recently expanded capabilities of its three logistics and supply centers, located strategically within the country, to quickly adjust to shifting product demands.

“Technology is only as good as the people who bring and support the solutions with our customers, ensuring long-term value and productivity,” says Kao. “Over the past two years, we have significantly grown our team of technical, sales and marketing professionals in key markets in Southeast Asia, China, Latin America and the United States to help customers succeed with our natural, mineral-based feed additives. An integral part of our commitment to our customers is to provide a professional staff with expertise to help them maximize their operations while meeting the high standards throughout the food chain.”

At IPPE this week, TECHTalks and oral abstract educational presentations by renowned poultry industry and Amlan experts are outlining new research and solutions for tackling poultry industry challenges. Following IPPE, information shared will be available at www.amlan.com.

Company Information
Amlan is the animal health business of Oil-Dri Corporation of America, leading global manufacturer and marketer of sorbent minerals. Oil-Dri leverages over 80 years of expertise in mineral science to selectively mine and process their unique mineral for consumer and business-to-business markets. Oil-Dri Corporation of America doing business as “Amlan International” is a publicly traded stock on the New York Stock Exchange (NYSE: ODC). Amlan International sells feed additives across the world. Product availability may vary by country, associated claims do not constitute medical claims and may differ based on government requirements.

Reagan Culbertson
Media Contact
press@amlan.com

Raised

Raised

TALLINN, Estonia, Jan. 25, 2022 (GLOBE NEWSWIRE) —  MyCointainer, a platform for easy yield staking, announced it has raised $6 million in a Seed Round. The event was led by Maple Block and co-led by Shima Capital & ByBit – one of the dominant cryptocurrency exchanges worldwide.

Numerous high-profile angel investors also participated in the round. Among them are entities with rich portfolios comprising some of the most renowned industry brands like CoinList, Circle, and Polygon. ConsenSys, Near, 1inch, Algorand, Polkadot, dY/dX, Casper Labs, Mina, Ankr, and Enjin are also there. Most importantly, their support enhances MyCointainer’s potential and pinpoints a tight-knit collaboration for future projects.

The company will use the funds to develop its yield-earning platform. This way, it will improve its current B2B products and expand its reach in Europe, Asia, the Middle East, and the rest of the world. Lastly, MyCointainer seeks to increase its expert team by hiring more professionals.

Yield Earning on MyCointainer

MyCointainer is a platform that enables customers to stake cryptocurrencies and tokens without any hassle. Users can start with as little as 1 EUR and have their pick from more than 100 digital assets, including Polkadot, Cardano, and Elrond.

Anyone can use MyCointainer to generate passive income through staking. The platform allows users to buy specific tokens or transfer them into their wallets. Then, it utilizes the power of blockchain protocols to generate more coins in the users’ balances as daily rewards.

Furthermore, participants can earn directly from their wallets through delegations. In other words, MyCointainer works like a digital piggy bank enabling people to enjoy their lives while their money works for them.

Some assets generating the best profits on MyCointainer are Cartesi, Polygon, NEM, Synthetic, and Cardano. On average, the yearly rewards are close to 15%.

Polygon is one of the most prestigious projects on MyCointainer, with almost 8,000 active participants at the time of writing. Furthermore, these users’ annual earnings are close to 12% on the platform.

Many consider Polygon as one of the potential payment forms of tomorrow. For instance, the project revolutionizes the blockchain community and creates a hub where users can interact with decentralized products. Above all, its presence on the platform enhances MyCointainer’s reliability and potential.

MyCointainer’s Rise in the Crypto World

Bartosz Pozniak, an entrepreneur with over 15 years of experience in shaping global digital products, founded and launched MyCointainer in 2018. Previously, he has worked in various industries, including investment banks, and in product teams for Barclays & Deutsche Bank in London.

Pozniak built MyCointainer in its early years through self-funding and company-generated revenue. So far, the platform has generated over $3 million in rewards for its over 110,000 users. The company has a financial institution license in Estonia. Also, its most important markets include the UK, the USA, France, and Italy.

In November 2021, MyCointainer joined forces with the industry-leading blockchain project Elrond and the Maiar Team. The partnership enables the trade of BTC/EGLD, EUR/EGLD pairs, and a simple proof-of-stake (PoS) mechanism. Also, it covers the patronage over the Maiar application. As a result, users can complete specific tasks and receive exclusive rewards from a total prize pool of $6,000 in EGLD.

Besides Elrond, MyCointainer has partnered with other important names in the industry, like Avalanche Labs, Waves & Cosmos. Also, the company worked closely with Crypto.com and many other fast and open blockchains for decentralized applications. These collaborations helped MyCointainer scale and grow its platform much further.

Lastly, the MyCointainer team is growing at a remarkable speed. Today, the company employs more than 42 people and plans to expand even more with several new positions opening. Anyone interested in the available roles can visit their Careers page.

About MyCointainer

MyCointainer has taken the ambitious mission of providing easy access to various rewarding crypto mechanisms for everyone. This way, everyone can benefit equally from a changing financial landscape and accelerate global crypto adoption.

The MyCointainer team is available on Facebook, Telegram, and Discord, among other social media channels.

Contact:

admin@vp-services.org

Related Images

Image 1: Raised

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Raised